Results 151 to 160 of about 10,630 (206)

Causative Role for a BRCA2 Germline Pathogenic Variant in External Auditory Canal Squamous Cell Carcinoma. [PDF]

Genes Chromosomes Cancer
Camacho-Valenzuela J, Pelletier D, Polak P, Fu L, Hamel N, Robles-Espinoza CD, Foulkes WD.   +6 more
europepmc   +1 more source

Delineation of the heterogeneity underlying genomic instability in hereditary breast cancers reveals four disease subtypes. [PDF]

Exp Mol Med
Kim S, Lee S, Kim H, Kang SJ, Chae H, Kim BJ, Kong J, Kang MC, Kim TM, Kong SY.   +9 more
europepmc   +1 more source

The ASH HematOmics Program supports integrative analysis of genomic and clinical data in hematologic diseases.

Blood
Lu C, Matt GY, Paul R, Wang J, Sioson E, Gangwani K, Acić A, Willems A, Zaldívar Peraza A, Reilly C, Pölönen P, Gao Q, Li Q, Pounds SB, Zeng AGX, Li S, Nadarajah N, Brady SW, Iacobucci I, Haferlach T, Rose MC, Mullighan CG, Zhou X.   +22 more
europepmc   +1 more source

Genomic determinants and an exploratory prognostic model for immunotherapy outcomes in recurrent or metastatic cervical cancer. [PDF]

Oncologist
Gu L, Zhu B, Liu C, Wu X, Zhang Y, Yin J, Wang F, Hu T, Wu Y.   +8 more
europepmc   +1 more source

The regulatory mechanism and clinical significance of RNA editing in prostate cancer. [PDF]

Curr Urol
Li S, Li A, Huang Y, Wang Y, Fan M, Jiang X, Bing K, Liang J, Wang K, Xu Z, Wang L.   +10 more
europepmc   +1 more source

Could chimeric antigen receptor-T cell treatment of atherosclerosis in mice translate to a human therapy? [PDF]

Ann Transl Med
Gieseg S, Hock B, Ogugofor M, McCormick S.   +3 more
europepmc   +1 more source

Endogenous DNA Damage and Its Role in Human Disease. [PDF]

Chem Res Toxicol
Bryan EM, Lauderback C.
europepmc   +1 more source

A comparative analysis of mutational profiles between triple-negative breast cancer and non-triple-negative breast cancer. [PDF]

Discov Oncol
Li W, Feng C, Zhou S.
europepmc   +1 more source

ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLC. [PDF]

Front Oncol
Santa-Catalina PG, Posado-Domínguez L, López-Gutiérrez Á, Del Barco Morillo E, Redondo-González JC, Egido-Iglesias N, Corvo-Félix L, Muela Bravo I, Rodrigues-Françoso A, Bellido-Hernández L, Fonseca-Sánchez E, Cruz-Hernández JJ, Corchado JM, García Hernández JL, Olivares-Hernández A.   +14 more
europepmc   +1 more source

High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities. [PDF]

Nat Commun
Chmelova L, Davies HR, Degasperi A, Rinaldi G, Wils L, Black D, Memari Y, Koh GCC, Shooter S, Mulder L, Kristel P, Szuhai K, Prasad G, Wong IT, Luebeck J, Kumar Y, Czarnecki J, Basyuni S, Kingsbury Z, Ross MT, Garred Ø, Riis M, Lande KT, Vallon-Christersson J, Ehinger A, Agrawal A, McIntosh SA, Bafna V, Mischel PS, Grand Challenges PRECISION Consortium, Wesseling J, Staaf J, Sørlie T, Lips EH, Nik-Zainal S.   +34 more
europepmc   +1 more source